Biosynthesis genes of etnangien an antibiotic drug candidate
The natural product etnangien represents a new structural type of a particularly efficient RNA polymerase inhibitor. It is effective against a broad panel of Gram-positive bacteria, including rifampicin resistant strains. Etnangien also retains activity against retroviral DNA polymerase and shows only low cytotoxicity against mammalian cell cultures, which add to the attractiveness for further development. The invention offers the possibility to heterologously produce etnangien in a production strain of different genera to finally optimise the fermentation conditions and the yields.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein
Media Contact
All latest news from the category: Technology Offerings
Newest articles
How the Immune System Learns from Harmless Particles
Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…
Biomarkers identified for successful treatment of bone marrow tumours
CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…
She deciphers how tomato roots communicate
Ora Hazak has always been fascinated by plants and is studying the signals that roots send to the rest of the organism. She aims to understand this communication in order…